Longtime Genzyme Holdout Meeker Passes Reigns To Sibold
Executive Summary
Bill Sibold will take over the leadership of Sanofi's Cambridge-based Genzyme group as the unit begins the important launch of Dupixent. Meeker ends his career at Genzyme after 23 years.